A new model for ductal carcinoma in situ suggests strategies for treatment

Gullick, William J. (2002) A new model for ductal carcinoma in situ suggests strategies for treatment. Breast Cancer Research, 4 (5). pp. 176-178. ISSN 1465-5411. (doi:10.1186/bcr447) (KAR id:3986)

PDF (A New Model for Ductal Carcinoma ) Language: English
Download this file (PDF/36kB)
Request a format suitable for use with assistive technology e.g. a screenreader
Official URL: http://dx.doi.org/10.1186/bcr447

Abstract

Human ductal carcinoma in situ (DCIS) of the breast is now diagnosed quite frequently, due largely to the introduction of mammographic screening. It has been shown in a cell culture system that activation of c-erbB-2, but not the epidermal growth factor receptor, results in a DCIS-like phenotype. Since overexpression of c-erbB-2 occurs in 60% of DCIS, this suggests that it could be a target for treatment in this disease.

Item Type:	Article
DOI/Identification number:	10.1186/bcr447
Additional information:	Free full-text article in PubMed Central and on Breast Cancer Research.
Uncontrolled keywords:	ductal carcinoma in situ, growth factor receptor, tyrosine kinase inhibitor
Subjects:	Q Science R Medicine > RC Internal medicine > RC254 Neoplasms. Tumors. Oncology
Divisions:	Divisions > Division of Natural Sciences > Biosciences
Depositing User:	William Gullick
Date Deposited:	04 Sep 2008 14:11 UTC
Last Modified:	16 Nov 2021 09:42 UTC
Resource URI:	https://kar.kent.ac.uk/id/eprint/3986 (The current URI for this page, for reference purposes)

University of Kent Author Information

Gullick, William J..

Creator's ORCID:
CReDIT Contributor Roles:

Depositors only (login required):

Altmetric

Download Statistics

Total unique views for this document in KAR since July 2020. For more details click on the image.